Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biocept (BIOCQ)
OTHER OTC:BIOCQ
Biocept (BIOCQ) Stock Price & Analysis
1,250 Followers
BIOCQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.00 - $13.43
Previous Close$0.13
Volume213.00
Average Volume (3M)1.38K
Market Cap
$263.00
Enterprise Value$4.47M
Total Cash (Recent Filing)$6.60M
Total Debt (Recent Filing)$11.06M
Price to Earnings (P/E)N/A
Beta-38.32
Next Earnings
May 15, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,626,026
10 Day Avg. Volume1,485
30 Day Avg. Volume1,383
Standard Deviation12.80
R-Squared0.00209
Alpha1.41
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.33
Enterprise Value/Gross Profit-1.73
Enterprise Value/Ebitda-0.14
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
80.87%
Insiders
0.33% Mutual Funds
5.00% Other Institutional Investors
13.80% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
BIOCQ FAQ
What was Biocept’s price range in the past 12 months?
Biocept lowest stock price was $0.00 and its highest was $13.43 in the past 12 months.
What is Biocept’s market cap?
Currently, no data Available
When is Biocept’s upcoming earnings report date?
Biocept’s upcoming earnings report date is May 15, 2024 which is in 15 days.
How were Biocept’s earnings last quarter?
Currently, no data Available
Is Biocept overvalued?
According to Wall Street analysts Biocept’s price is currently Overvalued.
Does Biocept pay dividends?
Biocept does not currently pay dividends.
What is Biocept’s EPS estimate?
Biocept’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biocept have?
Biocept has 2,626,026 shares outstanding.
What happened to Biocept’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biocept?
Among the largest hedge funds holding Biocept’s share is Hussman Strategic Advisors Inc. It holds Biocept’s shares valued at N/A.
---
Company Description
Biocept
Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.
---
BIOCQ Stock 12 Months Forecast
Average Price Target
―---